BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34750978)

  • 1. Anticancer Activity and Mechanism of Action Evaluation of an Acylhydrazone Cu(II) Complex toward Breast Cancer Cells, Spheroids, and Mammospheres.
    Balsa LM; Rodriguez MR; Parajón-Costa BS; González-Baró AC; Lavecchia MJ; León IE
    ChemMedChem; 2022 Feb; 17(4):e202100520. PubMed ID: 34750978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
    Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
    Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer and antimetastatic activity of copper(II)-tropolone complex against human breast cancer cells, breast multicellular spheroids and mammospheres.
    Balsa LM; Ruiz MC; Santa Maria de la Parra L; Baran EJ; León IE
    J Inorg Biochem; 2020 Mar; 204():110975. PubMed ID: 31911364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoxazole-Derived Aroylhydrazones and Their Dinuclear Copper(II) Complexes Show Antiproliferative Activity on Breast Cancer Cells with a Potentially Alternative Mechanism Of Action.
    Rada JP; Forté J; Gontard G; Corcé V; Salmain M; Rey NA
    Chembiochem; 2020 Sep; 21(17):2474-2486. PubMed ID: 32282111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
    Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
    Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
    Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
    Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper(ii) complexes with tridentate halogen-substituted Schiff base ligands: synthesis, crystal structures and investigating the effect of halogenation, leaving groups and ligand flexibility on antiproliferative activities.
    Kordestani N; Amiri Rudbari H; Fernandes AR; Raposo LR; Luz A; Baptista PV; Bruno G; Scopelliti R; Fateminia Z; Micale N; Tumanov N; Wouters J; Abbasi Kajani A; Bordbar AK
    Dalton Trans; 2021 Mar; 50(11):3990-4007. PubMed ID: 33650599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cu/ligand stoichiometry effect on the coordination behavior of aroyl hydrazone with copper(II): Structure, anticancer activity and anticancer mechanism.
    Deng J; Gou Y; Chen W; Fu X; Deng H
    Bioorg Med Chem; 2016 May; 24(10):2190-8. PubMed ID: 27056799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cu(II), Mn(II) and Zn(II) complexes of hydrazones with a quaternary ammonium moiety: synthesis, experimental and theoretical characterization and cytotoxic activity.
    Stevanović N; Zlatar M; Novaković I; Pevec A; Radanović D; Matić IZ; Đorđić Crnogorac M; Stanojković T; Vujčić M; Gruden M; Sladić D; Anđelković K; Turel I; Čobeljić B
    Dalton Trans; 2021 Dec; 51(1):185-196. PubMed ID: 34877947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dinuclear Cu(I) complexes of pyridyl-diazadiphosphetidines and aminobis(phosphonite) ligands: synthesis, structural studies and antiproliferative activity towards human cervical, colon carcinoma and breast cancer cells.
    Rashid A; Ananthnag GS; Naik S; Mague JT; Panda D; Balakrishna MS
    Dalton Trans; 2014 Aug; 43(29):11339-51. PubMed ID: 24922341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum-Targeting Copper(II) Complex.
    Kaur P; Johnson A; Northcote-Smith J; Lu C; Suntharalingam K
    Chembiochem; 2020 Dec; 21(24):3618-3624. PubMed ID: 32776422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate.
    Cai DH; Zhang CL; Liu QY; He L; Liu YJ; Xiong YH; Le XY
    Eur J Med Chem; 2021 Mar; 213():113182. PubMed ID: 33486198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.
    Deng J; Chen W; Deng H
    J Fluoresc; 2016 Nov; 26(6):1987-1996. PubMed ID: 27488686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Apoptosis by Nano-Synthesized Complexes of H2L and its Cu(II) Complex in Human Hepatocellular Carcinoma Cells.
    Diab T; Mohamed TM; Hamed A; Gaber M
    Anticancer Agents Med Chem; 2021; 21(9):1151-1159. PubMed ID: 32013853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
    Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
    Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
    Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
    J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Characterization, and in Vitro Anticancer Activity of Copper and Zinc Bis(Thiosemicarbazone) Complexes.
    Anjum R; Palanimuthu D; Kalinowski DS; Lewis W; Park KC; Kovacevic Z; Khan IU; Richardson DR
    Inorg Chem; 2019 Oct; 58(20):13709-13723. PubMed ID: 31339305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, crystal structure and biological evaluation of a new dasatinib copper(II) complex as telomerase inhibitor.
    Qin QP; Meng T; Tan MX; Liu YC; Luo XJ; Zou BQ; Liang H
    Eur J Med Chem; 2018 Jan; 143():1597-1603. PubMed ID: 29133054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel chiral tetranucleate copper-based complexes: crystal structures, nanoparticles, and inhibiting angiogenesis and the growth of human breast cancer by regulating the VEGF/VEGFR2 signal pathway in vitro.
    Zhang PL; Hou XX; Liu MR; Huang FP; Qin XY
    Dalton Trans; 2020 May; 49(18):6043-6055. PubMed ID: 32319484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure and in vitro pharmacological evaluation of a novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (2'-methylbenzoyl) hydrazone bridged copper(II) coordination polymer.
    Senthil Raja D; Ramachandran E; Bhuvanesh NS; Natarajan K
    Eur J Med Chem; 2013 Jun; 64():148-59. PubMed ID: 23644198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.